Cargando…
Correction to: Efficacy and Pharmacodynamic Target Attainment for Ceftazidime–Avibactam Off-Label Dose Regimens in Patients with Continuous or Intermittent Venovenous Hemodialysis: Two Case Reports
Autores principales: | Zhang, Xiao-Shan, Wang, Yu-Zhen, Shi, Da-Wei, Xu, Fang-Min, Yu, Jun-Hui, Chen, Jie, Lin, Guan-Yang, Zhang, Chun-Hong, Yu, Xu-Ben, Tang, Cong-Rong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Healthcare
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9669286/ https://www.ncbi.nlm.nih.gov/pubmed/36333476 http://dx.doi.org/10.1007/s40121-022-00675-z |
Ejemplares similares
-
Efficacy and Pharmacodynamic Target Attainment for Ceftazidime–Avibactam Off-Label Dose Regimens in Patients with Continuous or Intermittent Venovenous Hemodialysis: Two Case Reports
por: Zhang, Xiao-Shan, et al.
Publicado: (2022) -
Ceftazidime‐Avibactam Population Pharmacokinetic Modeling and Pharmacodynamic Target Attainment Across Adult Indications and Patient Subgroups
por: Li, Jianguo, et al.
Publicado: (2018) -
Population Pharmacokinetic Modeling and Probability of Pharmacodynamic Target Attainment for Ceftazidime‐Avibactam in Pediatric Patients Aged 3 Months and Older
por: Franzese, Richard C., et al.
Publicado: (2021) -
Ceftazidime-avibactam
por: Matesanz, Mayra, et al.
Publicado: (2021) -
Ceftazidime-avibactam
por: Herrero, Francisco Sanz
Publicado: (2022)